These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7780607)

  • 1. Evolving strategies for the management of non-palpable breast abnormalities.
    Kurtzman SH; MacGillivray DC; Deckers PJ
    Surg Oncol; 1995 Feb; 4(1):1-14. PubMed ID: 7780607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic contrast-enhanced MR imaging in screening detected microcalcification lesions of the breast: is there any value?
    Uematsu T; Yuen S; Kasami M; Uchida Y
    Breast Cancer Res Treat; 2007 Jul; 103(3):269-81. PubMed ID: 17063274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging of the breast.
    Birjawi G; El Zein Y
    J Med Liban; 2009; 57(1):47-54. PubMed ID: 19459577
    [No Abstract]   [Full Text] [Related]  

  • 4. Prospective evaluation of the value of combined mammographic and sonographic assessment in patients with palpable abnormalities of the breast.
    Shetty MK; Shah YP; Sharman RS
    J Ultrasound Med; 2003 Mar; 22(3):263-8; quiz 269-70. PubMed ID: 12636326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 99Tcm-MIBI scintimammography in the evaluation of breast lesions and axillary involvement: a comparison with mammography and histopathological diagnosis.
    Arslan N; Oztürk E; Ilgan S; Urhan M; Karaçalioglu O; Pekcan M; Tufan T; Bayhan H
    Nucl Med Commun; 1999 Apr; 20(4):317-25. PubMed ID: 10319351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Percutaneous stereotactic biopsy of non-palpable breast lesions using the Advanced Breast Biopsy Instrumentation (ABBI) system: critical evaluation of indication strategies].
    Wedegärtner U; Otto U; Buitrago-Tellez C; Bremerich J; Oertli D; Torhorst J; Bongartz G
    Rofo; 2001 Mar; 173(3):224-8. PubMed ID: 11293864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of abnormal mammography results and palpable breast abnormalities.
    Kerlikowske K; Smith-Bindman R; Ljung BM; Grady D
    Ann Intern Med; 2003 Aug; 139(4):274-84. PubMed ID: 12965983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Non palpable lesions of the breast: the Mammotome-biopsy in the preoperative management of breast cancer].
    Ceccarelli G; Casciola L; Battistini I; Stefanoni M; Spaziani A; Conti D; Di Zitti L; Valeri R; Bartoli A; Bellochi R; Rambotti M; Pisanelli MC
    G Chir; 2005 May; 26(5):187-93. PubMed ID: 16184700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The diagnostic sensitivity of dynamic contrast-enhanced magnetic resonance imaging and breast-specific gamma imaging in women with calcified and non-calcified DCIS.
    Kim JS; Lee SM; Cha ES
    Acta Radiol; 2014 Jul; 55(6):668-75. PubMed ID: 24043881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of common breast problems: guidance for primary care providers.
    Cady B; Steele GD; Morrow M; Gardner B; Smith BL; Lee NC; Lawson HW; Winchester DP
    CA Cancer J Clin; 1998; 48(1):49-63. PubMed ID: 9449933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ["Breast charter 2004". Diagnostic approach to breast pathology].
    Di Maggio C; Del Favero C; Frigerio A; Giuseppetti GM; Gozzi G; Lattanzio E; Pesce B; Rosselli Del Turco M; Simonetti G; Nosenzo MA
    Radiol Med; 2004; 108(5-6):569-87. PubMed ID: 15723003
    [No Abstract]   [Full Text] [Related]  

  • 12. [Stereotactic core biopsy of breast microcalcifications. Aid to diagnosis?].
    Chopier J; Seror JY; Antoine M; Sananes S; Merviel P; Amram S; Uzan S; Bigot JM
    J Radiol; 1997 Nov; 78(11):1141-6. PubMed ID: 9499951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Scintimammography with 99mTC-MIBI in the clinical practice: repercussion on the clinical management of the patient].
    Prats E; Razola P; Sainz JM; Tardín L; Andrés A; Abós MD; García F; Fernández J; Villavieja L; Banzo J
    Rev Esp Med Nucl; 2007; 26(3):153-9. PubMed ID: 17524309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benign versus malignant breast disease: comparison of contrast-enhanced MR imaging and Tc-99m tetrofosmin scintimammography.
    Fenlon HM; Phelan NC; O'Sullivan P; Tierney S; Gorey T; Ennis JT
    Radiology; 1997 Oct; 205(1):214-20. PubMed ID: 9314988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accuracy of mammographic appearances after breast fine-needle aspiration.
    Hindle WH; Chen EC
    Am J Obstet Gynecol; 1997 Jun; 176(6):1286-90; discussion 1290-2. PubMed ID: 9215186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microcalcification on mammography: approaches to interpretation and biopsy.
    Wilkinson L; Thomas V; Sharma N
    Br J Radiol; 2017 Jan; 90(1069):20160594. PubMed ID: 27648482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mammography immediately after stereotaxic breast biopsy: is it necessary?
    Hann LE; Liberman L; Dershaw DD; Cohen MA; Abramson AF
    AJR Am J Roentgenol; 1995 Jul; 165(1):59-62. PubMed ID: 7785633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MR imaging of the breast.
    Weinreb JC; Newstead G
    Radiology; 1995 Sep; 196(3):593-610. PubMed ID: 7644617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnosis of non-palpable breast lesions: contribution of cytological punctures after stereotaxic localization].
    Meunier M; Le Gal M; Klijanienko J; Vielh P; Neuenschwander S; Durand JC; Asselain B
    J Radiol; 1995 May; 76(5):259-62. PubMed ID: 7783038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New screening techniques for breast cancer (MRI).
    Gilbert FJ
    Dis Markers; 1999 Oct; 15(1-3):115-6. PubMed ID: 10595263
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.